Technology news and Jobs arrow VIRTUALISATION arrow Magnetize depression away
Magnetize depression away E-mail
by William Atkins   
Monday, 03 November 2008
The U.S. Food and Drug Administrtion (FDA) approves transcranial magnetic stimulation (TMS) as a treatment for depression for those unable to respond to traditional antidepressant drug therapies.


Transcranial magnetic stimulation (which is abbreviated TMS) uses an electromagnetic coil that is placed over the head of the patient.

See a picture of the device at: TMS Device.

The coil then delivers concentrated magnetic pulses—the strength of magnetic pulses used for magnetic resonance imaging (MRI) scans—to the brain in order to induce a weak electric current to brain tissue.

The device works when the coil’s magnetic field excites nerve cells in the brain that regulate mood.

According to the New Scientist article “Brain tickler,” Andrew Thomas, a spokesperson for United Kingdom-based The Magstim Company, stated, “It is a very significant step forward, as everyone looks to the U.S. as the leader.” [New Scientist, October 25-31, 2008, page 7]

The 40-minute procedure is usually administered daily for four to six weeks, and will be available through outpatient care.

The approval of the new depression treatment, which was announced by FDA on October 8, 2008, is based on studies with 164 patients who had major depression but were unable to eliminate their symptoms with traditional drug therapies.

The results of the experiment is found on page two.



 
< Next story in category   Previous story in the category >
iTWire user statistics Visitors last 30 days
694,279
Subscribers 15,210
#1 independent technology news advertise here
  •   *  
  • Search
  • AdvSeach
  • Login
  • Events
  • FreeStuff

- Advertisement -

Featured Whitepapers

Follow iTWire on Twitter

About iTWire

iTWire is all about technology news, information, jobs and community for the IT and telecommunications industry professional. Subscribe to our free ICT daily newsletter